A prospective, multi‐centre, Veterinary Radiation Therapy Oncology Group study reveals potential efficacy of toceranib phosphate (Palladia) as a primary or adjuvant agent in the treatment of canine nasal carcinoma-Reference-Cited by-同舟云学术

A prospective, multi‐centre, Veterinary Radiation Therapy Oncology Group study reveals potential efficacy of toceranib phosphate (Palladia) as a primary or adjuvant agent in the treatment of canine nasal carcinoma

Published:2021-10-26 Issue: Volume: Page:
ISSN:1476-5810
Container-title:Veterinary and Comparative Oncology
language:en
Short-container-title:Vet Comp Oncol

Author:

Ehling Tara Jean¹²^ORCID,Klein Mary Kay²,Smith Lauren²^ORCID,Prescott Deborah³,Haney Siobhan⁴,Looper Jayme⁵,LaDue Tracey⁶,Brawner William⁷,Fidel Janean⁸,Shiomitsu Keijiro⁹^ORCID,Green Eric¹⁰,Saba Corey¹¹^ORCID,Turek Michelle¹¹,Farrelly John¹²

Affiliation:

1. Veterinary Health Center of Wentzville, Department of Veterinary Medicine and Surgery University of Missouri Wentzville Missouri USA

2. Southwest Veterinary Oncology Tucson Arizona USA

3. MedVet Ohio Worthington Ohio USA

4. Hope Veterinary Specialists Malvern Pennsylvania USA

5. Chicago Veterinary Internal Medicine & Oncology Chicago Illinois USA

6. Southeast Veterinary Oncology Orange Park Florida USA

7. Department of Clinical Sciences at the College of Veterinary Medicine Auburn University Auburn Alabama USA

8. Veterinary Clinical Sciences, College of Veterinary Medicine Washington State University Pullman Washington USA

9. Department of Small Animal Clinical Sciences, College of Veterinary Medicine University of Florida Gainesville Florida USA

10. Veterinary Clinical Sciences Ohio State University Columbus Ohio USA

11. Department of Small Animal Medicine & Surgery, College of Veterinary Medicine University of Georgia Athens Georgia USA

12. BluePearl Veterinary Partners Tampa Florida USA

Funder

Zoetis

Publisher

Wiley

Subject

General Veterinary

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/vco.12776

Reference40 articles.

1. Nasal tumors in the dog: retrospective evaluation of diagnosis, prognosis, and treatment;MacEwen EG;J Am Vet Med Assoc,1977

2. Neoplasms of the nasal passages and paranasal sinuses in domesticated animals as reported by 13 veterinary colleges;Madewell BR;Am J Vet Res,1976

3. Prognostic factors and survival after radiotherapy for intranasal neoplasms in dogs: 70 cases (1974–1985);Evans SM;J Am Vet Med Assoc,1989

4. Survival in Dogs with Nasal Adenocarcinoma: 64 Cases (1981-1995)

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Expression of vascular endothelial growth factor receptor-2, epidermal growth factor receptor, cyclooxygenase-2, survivin, E-cadherin and Ki-67 in canine nasal carcinomas and sarcomas – a pilot study;Frontiers in Veterinary Science;2024-08-29

2. Investigation of Gastrointestinal Toxicities Associated with Concurrent Abdominal Radiation Therapy and the Tyrosine Kinase Inhibitor Sunitinib in a Mouse Model;International Journal of Molecular Sciences;2024-02-02

3. Cancers in Dogs and Cats;Hospice and Palliative Care for Companion Animals;2023-03-26

4. Frontal sinus carcinoma in forty‐one dogs (2001–2022);Veterinary and Comparative Oncology;2023-02-14

5. Toceranib phosphate and firocoxib-mediated partial response in a dog with advanced intranasal sarcoma;Journal of Veterinary Medical Science;2023